BrightGene Bio Medical Technology C (688166) — Net Asset Quality Index
BrightGene Bio Medical Technology C (688166) has a Net Asset Quality Index of 48.0% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.38 Billion minus total liabilities of CN¥2.80 Billion yields net assets of CN¥2.59 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of BrightGene Bio Medical Technology C for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
BrightGene Bio Medical Technology C Net Asset Quality Index Over Time (2016–2024)
This chart shows how BrightGene Bio Medical Technology C's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 48.0%, representing net assets of CN¥2.59 Billion against total assets of CN¥5.38 Billion CNY. For live market cap and overall valuation, see BrightGene Bio Medical Technology C market cap and net worth.
Annual Net Asset Quality Index for BrightGene Bio Medical Technology C (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for BrightGene Bio Medical Technology C from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 688166 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 47.2% | CN¥2.44 Billion | CN¥5.16 Billion | CN¥2.73 Billion | ▼ -0.8 pp |
| 2023 | 48.0% | CN¥2.42 Billion | CN¥5.03 Billion | CN¥2.61 Billion | ▼ 0.0 pp |
| 2022 | 48.1% | CN¥2.24 Billion | CN¥4.66 Billion | CN¥2.42 Billion | ▼ -10.6 pp |
| 2021 | 58.6% | CN¥1.74 Billion | CN¥2.97 Billion | CN¥1.23 Billion | ▼ -19.7 pp |
| 2020 | 78.4% | CN¥1.43 Billion | CN¥1.83 Billion | CN¥395.23 Million | ▼ -14.0 pp |
| 2019 | 92.4% | CN¥1.31 Billion | CN¥1.42 Billion | CN¥108.21 Million | ▲ +4.4 pp |
| 2018 | 88.0% | CN¥772.85 Million | CN¥878.37 Million | CN¥105.52 Million | ▲ +3.0 pp |
| 2017 | 85.0% | CN¥446.02 Million | CN¥524.92 Million | CN¥78.89 Million | ▲ +27.7 pp |
| 2016 | 57.3% | CN¥220.15 Million | CN¥384.19 Million | CN¥164.05 Million | — |